Figure S1 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Autor: Jessica A. Pollard, Soheil Meshinchi, Alan S. Gamis, Irwin Bernstein, Richard Aplenc, Lillian Sung, Betsy Hirsch, Susana C. Raimondi, Leela Sarukkai, Jason Joaquin, Tiffany Hylkema, Laura Pardo, Michael R. Loken, Rhonda Ries, Robert B. Gerbing, Yi-Cheng Wang, Todd A. Alonzo, Katherine Tarlock
Rok vydání: 2023
Popis: Supplemental Figure 1. (A) KIT mutational status of the cohort; (B) Prevalence of CBF subtype among the E8 and E17 mutations. (B) Among E8 mutations, 54% of patients were inv(16) and 46% were t(8;21). (C) Among E17 mutations, 37% of patients were inv(16) and 63% were t(8;21).
Databáze: OpenAIRE